Zotizalkib ( TPX-0131 ) | CAS 2648641-36-3

Zotizalkib ( TPX-0131 )
2648641-36-3

询价 50mg 起订

100mg 起订

500mg 起订

湖北更新日期：2024-05-22

武汉永璨生物科技有限公司

VIP14年

联系人：崔经理

电话：17702719238拨打

手机：17702719238 拨打

邮箱：sales@sun-shinechem.com

产品详情:

中文名称：: Zotizalkib ( TPX-0131 )

英文名称：: Zotizalkib ( TPX-0131 )

CAS号：: 2648641-36-3

纯度规格：: 98.0% HPLC

产品类别：: APIS

Zotizalkib ( TPX-0131 )：: Zotizalkib ( TPX-0131 ) | ALK inhibitor

TPX-0131 is a next-generation ALK inhibitor drug candidate currently being evaluated in our Phase 1/2 FORGE-1 clinical trial of patients with ALK+ advanced non-small lung cancer (NSCLC). It has been designed with a novel compact macrocyclic structure and has shown preclinical potent inhibition of wildtype and numerous ALK mutations, including the clinically observed G1202R solvent-front mutation and the G1202R/L1196M compound mutation.

Zotizalkib;TPX-0131;2648641-36-3;

公司简介

Wuhan Sun-shine Bio-technology Corporation Limited (Shanghai Sun-shine Chemical Technology Corporation Limited) is a high-tech enterprise engaged inR&D and sales of related compounds of new drugs, specialty pharmaceutical API, advanced intermediates, organic synthetic masonry, and high-end reagents, etc. The special services we provide include: the technical development of chiral drugs, the development of an active molecular library.

成立日期	(12年)
注册资本	壹拾万元整
员工人数	10-50人
年营业额	￥ 500万-1000万
经营模式	工厂,定制,服务
主营行业	中间体,医药原料